Company intelligence / Profile preview

Yali Pharmaceuticals

South San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Yali Bio develops climate-friendly fats using precision fermentation and synthetic biology to create better plant-based lipids for use in alternative dairy products such as butter and ice cream. Their technology enables more sustainable fat production with fewer inputs than conventional sources. They are among the first to address plant-based fats through precision fermentation rather than cell cultivation.

Modalities: Precision fermentation (for lipid production)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Yali Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yali Pharmaceuticals.

Explore the full profile